Israeli government finalizes an agreement with Pfizer to purchase 100,000 courses of the anti-viral drug Paxlovid for high-risk patients over the age of 12 years,
The Israeli government finalizes an agreement with Pfizer to purchase 100,000 courses of the anti-viral drug Paxlovid for high-risk patients over the age of 12 years, with delivery expected to begin in one week.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthIsraeli government finalizes an agreement with Pfizer to purchase 100,000 courses of the anti-viral drug Paxlovid for high-risk patients over the age of 12 years,
View Premium plansBrowse free archive reportsThe Israeli government finalizes an agreement with Pfizer to purchase 100,000 courses of the anti-viral drug Paxlovid for high-risk patients over the age of 12 years, with delivery expected to begin in one week.